Pfizer and German partner BioNTech on Monday asked the U.S. Patent and Trademark Office to reconsider, and ultimately invalidate, Moderna’s patents over core technologies of the COVID-19 vaccine, Reuters reported.
Tag Archive for: U.S. Patent and Trademark Office
A U.S. appeals court handed Moderna Inc. a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp. patent related to the companies’ legal fight over Moderna’s blockbuster COVID-19 vaccines.